Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2642 (LINC02642)

Target
LINC02642
Molecular classification
Long intergenic non-protein coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 2642 (LINC02642) is a human gene encoding a long non-coding RNA, described as part of the lincRNA family, which are transcripts longer than 200 nucleotides, located in genomic regions that do not overlap protein-coding genes[1][3][5][8]. LincRNAs are generally nuclear, often tissue-specific, and can regulate gene expression, modulate chromatin structure, and participate in transcriptional control, though the specific biological role or clinical importance of LINC02642 itself has not been characterized in the current literature[1][3][5][8]. LINC02642 is part of a rapidly expanding class of non-protein coding RNA genes; lincRNAs are frequently involved in gene regulation, but specific functions must be individually validated[8]. There is no evidence at present designating LINC02642 as a drug target, disease biomarker, or receptor, nor any drug-targeting information[1][3][5]. Absence of information on clinical, pathological, or therapeutic relevance means LINC02642 is not considered a therapeutic target at this time[1][3][5][8]. If precise molecular function, disease association, or drug targeting are identified in the future, these entries should be updated accordingly.

Other names
LINC02642
02

Biological functions

Gene regulation (presumed, not experimentally confirmed for LINC02642 specifically)Chromatin remodeling and transcription regulation (general for lincRNAs, not confirmed for LINC02642)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2642 (LINC02642).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2642 (LINC02642).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call